News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
15,819 Results
Type
Article (2373)
Company Profile (7)
Press Release (13439)
Section
Business (6317)
Career Advice (87)
Deals (928)
Drug Delivery (11)
Drug Development (2525)
Employer Resources (15)
FDA (432)
Job Trends (732)
News (9868)
Policy (845)
Tag
2024 Genetown Digital (1)
Academia (52)
Adcomms (5)
Allergies (1)
Alliances (1244)
ALS (4)
Alzheimer's disease (31)
Antibody-drug conjugate (ADC) (16)
Approvals (420)
Artificial intelligence (7)
Autoimmune disease (1)
Bankruptcy (10)
Best Places to Work (600)
BIOSECURE Act (1)
Biosimilars (2)
Biotechnology (2)
Bladder cancer (1)
Brain cancer (2)
Breast cancer (6)
Cancer (99)
Cardiovascular disease (8)
Career advice (74)
Career pathing (3)
CAR-T (28)
Cell therapy (47)
Cervical cancer (1)
Clinical research (2074)
Collaboration (31)
Compensation (1)
Complete response letters (1)
COVID-19 (61)
CRISPR (2)
C-suite (22)
Data (35)
Depression (6)
Diabetes (1)
Diagnostics (78)
Diversity, equity & inclusion (4)
Drug discovery (5)
Drug pricing (27)
Duchenne muscular dystrophy (2)
Earnings (1713)
Editorial (7)
Employer branding (7)
Employer resources (12)
Events (1818)
Executive appointments (52)
FDA (447)
Funding (29)
Gene editing (6)
Gene therapy (4)
GLP-1 (36)
Government (131)
Guidances (1)
Healthcare (378)
Huntington's disease (2)
IgA nephropathy (1)
Immunology and inflammation (9)
Indications (1)
Infectious disease (63)
Inflammatory bowel disease (6)
Inflation Reduction Act (4)
Interviews (19)
IPO (340)
IRA (22)
Job creations (150)
Job search strategy (63)
Kidney cancer (2)
Labor market (1)
Layoffs (54)
Leadership (2)
Legal (224)
Liver cancer (8)
Lung cancer (16)
Lymphoma (7)
Management (2)
Manufacturing (4)
Medical device (77)
Medtech (77)
Mergers & acquisitions (585)
Metabolic disorders (8)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (5)
Neuropsychiatric disorders (7)
Neuroscience (69)
NextGen: Class of 2025 (236)
Non-profit (138)
Northern California (52)
Now hiring (3)
Obesity (5)
Opinion (27)
Ovarian cancer (3)
Pain (1)
Pancreatic cancer (1)
Parkinson's disease (3)
Patents (6)
Patient recruitment (1)
People (2951)
Pharmaceutical (5)
Pharmacy benefit managers (3)
Phase I (622)
Phase II (839)
Phase III (920)
Pipeline (38)
Podcasts (8)
Policy (27)
Postmarket research (123)
Preclinical (123)
Prostate cancer (5)
Psychedelics (3)
Radiopharmaceuticals (21)
Rare diseases (17)
Real estate (127)
Recruiting (6)
Regulatory (553)
Reports (1)
Research institute (91)
Resumes & cover letters (10)
RSV (2)
Schizophrenia (28)
Series A (8)
Series B (9)
Sickle cell disease (4)
Southern California (36)
Special edition (2)
Sponsored (1)
Startups (163)
Stomach cancer (5)
The Weekly (8)
United States (404)
Vaccines (18)
Venture capitalists (10)
Webinars (1)
Weight loss (7)
Date
Today (4)
Last 7 days (16)
Last 30 days (77)
Last 365 days (956)
2025 (164)
2024 (959)
2023 (958)
2022 (1740)
2021 (1679)
2020 (1462)
2019 (1093)
2018 (846)
2017 (905)
2016 (623)
2015 (808)
2014 (519)
2013 (474)
2012 (446)
2011 (483)
2010 (404)
Location
Africa (32)
Asia (942)
Australia (102)
California (103)
Canada (17)
China (8)
Colorado (3)
Connecticut (9)
Delaware (3)
Europe (2184)
Florida (44)
Georgia (1)
Illinois (8)
Indiana (1)
Japan (6)
Kansas (2)
Maryland (8)
Massachusetts (85)
Minnesota (2)
New Hampshire (2)
New Jersey (51)
New Mexico (1)
New York (15)
North Carolina (19)
Northern California (52)
Ohio (3)
Pennsylvania (11)
South America (39)
Southern California (36)
Tennessee (2)
Texas (15)
Virginia (18)
Washington D.C. (4)
Washington State (11)
Wisconsin (1)
15,819 Results for "bristol myers squibb".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bristol Myers Squibb Announces Dividend - March 3, 2025
March 3, 2025
·
1 min read
Press Releases
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
March 4, 2025
·
4 min read
Press Releases
Bristol Myers Squibb to Participate in Upcoming March 2025 Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial
February 14, 2025
·
19 min read
Press Releases
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2024
February 6, 2025
·
19 min read
Press Releases
Bristol Myers Squibb Announces Dividend Increase
December 12, 2024
·
1 min read
Press Releases
Rancho BioSciences Announces Bristol Myers Squibb Renews Membership for Phase 2 of the Single-Cell Data Science Consortium
February 18, 2025
·
2 min read
Biotech Bay
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb
Scenic Biotech announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb’s drug targets by identifying target biology for indication selection and expansion.
April 30, 2024
·
2 min read
Business
Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors
Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected independent director Michael R. McMullen to the Board, effective July 1, 2024.
June 18, 2024
·
3 min read
Job Trends
European Medicines Agency Validates Bristol Myers Squibb’s Application for Subcutaneous Nivolumab
Bristol Myers Squibb (NYSE: BMY) today announced that the European Medicines Agency (EMA) has validated the extension application to introduce a new route of administration (subcutaneous use) for Opdivo®.
June 21, 2024
·
45 min read
1 of 1,582
Next
